Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Return on Capital Employed (2016 - 2021)

Phio Pharmaceuticals' Return on Capital Employed history spans 10 years, with the latest figure at 0.46% for Q3 2021.

  • For Q3 2021, Return on Capital Employed rose 7.0% year-over-year to 0.46%; the TTM value through Sep 2021 reached 0.46%, up 7.0%, while the annual FY2020 figure was 0.91%, 1.0% up from the prior year.
  • Return on Capital Employed reached 0.46% in Q3 2021 per PHIO's latest filing, down from 0.37% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.37% in Q2 2021 to a low of 8.61% in Q1 2018.
  • Average Return on Capital Employed over 5 years is 1.89%, with a median of 0.94% recorded in 2018.
  • Peak YoY movement for Return on Capital Employed: tumbled -718bps in 2018, then skyrocketed 805bps in 2019.
  • A 5-year view of Return on Capital Employed shows it stood at 5.02% in 2017, then skyrocketed by 81bps to 0.94% in 2018, then tumbled by -33bps to 1.25% in 2019, then soared by 53bps to 0.59% in 2020, then grew by 23bps to 0.46% in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Return on Capital Employed are 0.46% (Q3 2021), 0.37% (Q2 2021), and 0.45% (Q1 2021).